Koninklijke Philips (PHG) Set to Announce Earnings on Monday

Koninklijke Philips (NYSE:PHG) is scheduled to announce its earnings results before the market opens on Monday, October 28th. Investors interested in participating in the company’s conference call can do so using this link.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 earnings per share for the quarter. Koninklijke Philips had a positive return on equity of 10.15% and a negative net margin of 2.35%. The firm had revenue of $4.80 billion during the quarter. On average, analysts expect Koninklijke Philips to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Koninklijke Philips Price Performance

Shares of Koninklijke Philips stock opened at $31.67 on Friday. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60. Koninklijke Philips has a twelve month low of $18.06 and a twelve month high of $32.91. The business has a 50-day moving average price of $31.05 and a 200 day moving average price of $27.61. The firm has a market cap of $29.77 billion, a PE ratio of -59.75, a P/E/G ratio of 1.05 and a beta of 0.74.

Analysts Set New Price Targets

Separately, StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Monday, July 15th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Koninklijke Philips presently has a consensus rating of “Hold”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.